Genesis BioCapital Fund I, LP — Form D/A
Genesis BioCapital Fund I, LP of CHATTANOOGA, TN, a pooled investment fund, filed a Form D amendment with the SEC on 2026-01-23. $18.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-01-23
- Form: D/A
- Accession: 0001493152-26-003327
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Amount sold: $18.5M
- Investors: 21
- Date of first sale: 2025-01-24
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-536080
Issuer
- Name: Genesis BioCapital Fund I, LP
- CIK: 0002053141
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 200 WEST MLK BLVD., CHATTANOOGA, TN, 37402
- Phone: 617-444-8400
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| - Genesis BioCapital Fund I GP, LP | Related Person | Chattanooga, TN |
| - Genesis BioCapital Management, LLC | Related Person | Chattanooga, TN |
| Ray Tabibiazar | Related Person | Chattanooga, TN |
| Ray Tabibiazar | Executive Officer | Chattanooga, TN |
| - Genesis BioCapital Management, LLC | Executive Officer | Chattanooga, TN |
| - Genesis BioCapital Fund I GP, LP | Executive Officer | Chattanooga, TN |
Other filings by this issuer (1)
More